கைட்லின் கிரெப்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கைட்லின் கிரெப்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கைட்லின் கிரெப்ஸ் Today - Breaking & Trending Today

Nalu Bio Partners with World-Class Scientists to Evaluate Synthetic CBD for Non-Opioid Pain Management


Share this article
Share this article
SAN FRANCISCO, March 4, 2021 /PRNewswire/ Nalu Bio, Inc. today announced a collaboration with Ken Mackie, M.D., Chair and Distinguished Professor at Indiana University s Gill Center for Biomolecular Science, to evaluate how the potency and efficacy of the company s proprietary synthetic cannabinoids - specifically their close-to-market cannabidiol (CBD) - may enable the development of effective non-opioid pain management.
Nalu Bio. Learning from nature, delivering through chemistry.
I am excited to bring a new category of chemistry-derived cannabinoids to patients worldwide -Prof. Mackie
Nalu Bio has developed a proprietary chemistry platform that enables highly efficient commercial production of organically synthesized cannabinoids. The collaboration with Prof. Mackie aims to demonstrate that synthetic CBD has the same potency and efficacy as plant-derived CBD. ....

Nalu Bio , Caitlyn Krebs , Nalu Bio Inc , Gill Center , Biomolecular Science At Indiana University Bloomington , Advisory Board , Biomolecular Science , Indiana University Bloomington , நலு உயிர் , கைட்லின் கிரெப்ஸ் , நலு உயிர் இன்க் , கில் மையம் , உயிர் மூலக்கூறு அறிவியல் இல் இந்தியானா பல்கலைக்கழகம் பூக்கும் , உயிர் மூலக்கூறு அறிவியல் , இந்தியானா பல்கலைக்கழகம் பூக்கும் ,

Nalu Bio has Successfully Synthesized Pure, High-quality CBD for Scale and Closed Its Seed Financing Round


Share this article
Share this article
SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ Nalu Bio, Inc. today announced the successful organic synthesis of CBD (cannabidiol) utilizing its proprietary technology platform, closure of its seed financing, and the successful recruitment of a world-class team of life science and consumer packaged goods professionals to develop and scale the company s innovative technology. Nalu Bio s vision for the organic synthesis and cost-effective mass production of CBD mimics the history of aspirin - the therapeutic value of aspirin for pain relief was uncovered, is now mass-produced in the lab, and has become the most commonly used drug in the world. ....

Nalu Bio , Phyllis Whiteley , Caitlyn Krebs , Alex Dorenbaum , Randall Ussery , Matthew Roberts , Reneo Pharmaceuticals , Prnewswire Nalu Bio Inc , Nalu Bio Inc , Clinical Professor At Stanford School Of Medicine , Lumena Pharmaceuticals , Nature Bounty Company , Health Happiness Group , Golden Seeds , Happiness Group , Chief Technology Officer , Chief Scientific Officer , Abbott Nutrition , Bounty Company , Chief Medical Officer , Biomarin Pharmaceutical , Clinical Professor , Stanford School , நலு உயிர் , ஃபிலிஸ் வைட்லி , கைட்லின் கிரெப்ஸ் ,